Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Lung Cancer. 2016 Nov 9;103:6–10. doi: 10.1016/j.lungcan.2016.11.005

Figure 1.

Figure 1

Results of 3-year OS estimates when 749 clinical Stage I NSCLC patients eligible for STARS and/or ROSEL were sampled 10,000 times (with replacement) in groups of 27, to simulate the actual combined surgical enrollment arms of STARS and ROSEL.